MedTrace Logo

Evaluation of a Non-face to Face Multidisciplinary Health Care Model in a Population With Rheumatoid Arthritis

NCT04768413 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2021-02-24

No results posted yet for this study

Summary

This research work proposes the evaluation of the implementation of a tele-orientation program and tele-consultation to the adult population with RA attended at a specialized rheumatology center in Bogota, Colombia, over a period of three months, by means of a observational, analytical, cohort, prospective study that will include mixed methods for collecting information (quantitative and qualitative)

Conditions

Interventions

OTHER

Teleconsultation either by phone or by computer consultation. Quantitative and qualitative approaches to analysis

A group of patients who have voluntarily adhered to the clinic's tele-assisted consultation and who receive remote, multidisciplinary team care without requiring physical displacement.

OTHER

Care modalities. Quantitative and qualitative approaches to analysis

Group of patients who wish to continue with the usual face-to-face consultation, since for these patient's isolation measures allow trips to the care centers and who receive care from a multidisciplinary team on a regular basis.

Sponsors & Collaborators

  • Biomab I.P.S. Centro de Atencion Integral en Artritis Reumatoide

    collaborator OTHER

  • Fundación Universitaria de Ciencias de la Salud

    lead OTHER

Principal Investigators

  • Adriana Rojas-Villarraga, MD;Rhe · FUNDACION UNIVERSITARIA DE CIENCIAS DE LA SALUD

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-01
Primary Completion
2021-04-30
Completion
2021-06-30

Countries

  • Colombia

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04768413 on ClinicalTrials.gov